LUX-Dx II+ Adverse Events: FDA MAUDE Data

BOSTON SCIENTIFIC CORPORATION · Insertable Cardiac Monitor (ICM/ILR) · First cleared Aug 2023

Total Reports

381

Reports (30d)

23

Active Signals

1

Open Recalls

3

Monthly Report Volume
Event Type Breakdown

Most commonly reported problems

1

Brady Monitoring Value Discrepancy

retrospective, brady monitor, brady, value enabled, brady monitoring

133

reports

2

Connection Failure with Mobile Monitor

insertable cardiac, battery, adverse, icm device, effects

43

reports

3

Programmed Settings Discrepancy with Pause

pause, settings displayed, displayed latitude, programmed settings, discrepancy

12

reports

Problem groupings are generated by Claripulse from report narrative text. They summarize what reporters wrote, not adjudicated root cause.

Active safety signals

Disproportionate reportinghigh

FDA recalls for this device

Class II

Mar 30, 2026 · Open, Classified

For some patients upgraded from a LUX-Dx M301 device to a new Model M302 or M312, the new ICM device is not collecting PVC Burden data (both M302/M312) or monitoring for Bradyarrhythmia and Pause (M312 only). In addition, for these devices that are not being monitored, the LATITUDE Clarity programming screens have discrepant information, indicating that the monitoring is enabled for these features in one location and not enabled in another location.

Class II

Mar 30, 2026 · Open, Classified

For some patients upgraded from a LUX-Dx M301 device to a new Model M302 or M312, the new ICM device is not collecting PVC Burden data (both M302/M312) or monitoring for Bradyarrhythmia and Pause (M312 only). In addition, for these devices that are not being monitored, the LATITUDE Clarity programming screens have discrepant information, indicating that the monitoring is enabled for these features in one location and not enabled in another location.

Class II

Sep 6, 2024 · Open, Classified

Patients using the Model 2939 myLUX Patient Application on their Apple mobile device (e.g., iPhone) may not be transmitting data from their Insertable Cardiac Monitor to the LATITUDE Clarity website.

Want automated safety signal detection?

Claripulse monitors these devices weekly and detects anomalies using 6 statistical methods — spike, trend, changepoint, peer-outlier, and more. 1 active signal detected right now.

Get Early Access
Disclaimer: This system analyzes publicly available FDA MAUDE data. It does NOT provide medical advice. MAUDE data is de-identified. Do not attempt re-identification. Report counts may differ from the FDA's MAUDE search due to processing cadence and deduplication. Data is updated weekly.